Mylan Launches Generic Viramune Tablets
Viramune is a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for combination antiretroviral treatment of HIV-1 infection. NNRTIs non-competitively bind to HIV-1 reverse transcriptase at a site far from the catalytic nucleoside/nucleotide binding site. This action causes a conformational change in the enzyme which dramatically reduces its activity.
Nevirapine tablets are available from Mylan in 12-count packs.
For more information call (800) RX-MYLAN or visit www.mylan.com.